In recent years, telehealth companies like Hims and Keeps have revolutionized access to hair loss treatments by offering ...
We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at ...
Gov. Wes Moore made lowering drug costs a key campaign promise, making advocates of the law confident that their greatest ...
Leading UCSF physician-scientists are developing targeted treatments, earlier diagnostics, and helping to solve tuberculosis’ ...
Ever since the Consumer Financial Protection Bureau opened in 2011 with a mandate to regulate financial institutions, its detractors have tried to eliminate it. They have questioned its ...
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...
The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...
The Centers for Disease Control and Prevention (CDC) recorded a 24% decline in overdose deaths in 2024 when compared to the previous 12-month range.
The drug's use was also on the rise in places like New York, where, in the following year, at least 95% of those admitted to ...
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results